164 related articles for article (PubMed ID: 11729421)
1. Antiplatelet therapy: a perspective from cardiology.
Zusman RM
Manag Care; 2000 Oct; 9(10 Suppl):5-8. PubMed ID: 11729421
[No Abstract] [Full Text] [Related]
2. Antiplatelet therapy: a perspective from cardiology.
Zusman RM
Manag Care; 2000 May; 9(5 Suppl):7-10. PubMed ID: 11729411
[No Abstract] [Full Text] [Related]
3. Antiplatelet agents prevent cardiac events in patients with coronary artery disease.
Ishikawa K
Intern Med; 1998 Feb; 37(2):199-202. PubMed ID: 9550609
[No Abstract] [Full Text] [Related]
4. [Drug therapy of coronary heart disease--are therapeutic guidelines being paid attention to?].
Böger GI; Hoopmann M; Busse R; Budinger M; Welte T; Böger RH
Z Kardiol; 2003 Jun; 92(6):466-75. PubMed ID: 12819995
[TBL] [Abstract][Full Text] [Related]
5. Antiplatelet drug resistance: not ready for prime time.
Burns TL; Mooss AN; Hilleman DE
Pharmacotherapy; 2005 Nov; 25(11):1621-8. PubMed ID: 16232023
[TBL] [Abstract][Full Text] [Related]
6. Antiplatelet pathways development. Panel discussion.
Ballenger J; Olin JW; Brass LM; Orland BI; Cannon E; Rich SJ; Dresdale A; Stemple C; Moreo K; Zusman R
Manag Care; 2000 May; 9(5 Suppl):18-24. PubMed ID: 11729409
[No Abstract] [Full Text] [Related]
7. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians.
Grines CL; Bonow RO; Casey DE; Gardner TJ; Lockhart PB; Moliterno DJ; O'Gara P; Whitlow P; ; ; ; ; ;
J Am Coll Cardiol; 2007 Feb; 49(6):734-9. PubMed ID: 17291948
[TBL] [Abstract][Full Text] [Related]
8. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians.
Grines CL; Bonow RO; Casey DE; Gardner TJ; Lockhart PB; Moliterno DJ; O'Gara P; Whitlow P; ; ; ; ; ;
Circulation; 2007 Feb; 115(6):813-8. PubMed ID: 17224480
[TBL] [Abstract][Full Text] [Related]
9. [Percutaneous coronary interventions in elderly patients: clinical indications and adjunctive medical treatment. The Italian Drug Evaluation in Angioplasty (IDEA) study].
Bossi I; Piccaluga E; Scatturin M; Corvaja N; Pasquetto G; Steffanon L; Oberhollenzer R; Colombo P; Bolognese L; Savonitto S
G Ital Cardiol (Rome); 2006 Feb; 7(2):136-44. PubMed ID: 16532725
[TBL] [Abstract][Full Text] [Related]
10. Antiplatelet effects of angiotensin-converting enzyme inhibitors compared with aspirin and clopidogrel: a pilot study with whole-blood aggregometry.
Bauriedel G; Skowasch D; Schneider M; Andrié R; Jabs A; Lüderitz B
Am Heart J; 2003 Feb; 145(2):343-8. PubMed ID: 12595854
[TBL] [Abstract][Full Text] [Related]
11. Glycoprotein IIb/IIIa inhibitors in patients with unstable angina/non-ST-segment elevation myocardial infarction: appropriate interpretation of the guidelines.
Antman EM
Am Heart J; 2003 Oct; 146(4 Suppl):S18-22. PubMed ID: 14564302
[TBL] [Abstract][Full Text] [Related]
12. Controversies of oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention.
Rajagopal V; Bhatt DL
Semin Thromb Hemost; 2004 Dec; 30(6):649-55. PubMed ID: 15630671
[TBL] [Abstract][Full Text] [Related]
13. Reduction in sex-based mortality difference with implementation of new cardiology guidelines.
Novack V; Cutlip DE; Jotkowitz A; Lieberman N; Porath A
Am J Med; 2008 Jul; 121(7):597-603.e1. PubMed ID: 18538296
[TBL] [Abstract][Full Text] [Related]
14. [20 years of cardiovascular epidemiology. The clinician's viewpoint].
Bertrand ME
Rev Epidemiol Sante Publique; 1996 Nov; 44(6):556-62. PubMed ID: 9005491
[TBL] [Abstract][Full Text] [Related]
15. Antiplatelet therapy in percutaneous coronary intervention: a critical review of the 2007 AHA/ACC/SCAI guidelines and beyond.
Cohen M
Catheter Cardiovasc Interv; 2009 Oct; 74(4):579-97. PubMed ID: 19472347
[TBL] [Abstract][Full Text] [Related]
16. Aspirin + clopidogrel therapy: how does your care compare to the evidence?
Simmons BB; Salzman BE
J Fam Pract; 2008 Jan; 57(1):26-32. PubMed ID: 18171566
[No Abstract] [Full Text] [Related]
17. Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE initiative.
Mehta RH; Roe MT; Chen AY; Lytle BL; Pollack CV; Brindis RG; Smith SC; Harrington RA; Fintel D; Fraulo ES; Califf RM; Gibler WB; Ohman EM; Peterson ED
Arch Intern Med; 2006 Oct; 166(18):2027-34. PubMed ID: 17030838
[TBL] [Abstract][Full Text] [Related]
18. Use of evidence-based management for acute coronary syndrome.
Tang E; Wong CK; Wilkins G; Herbison P; Williams M; Kay P; Restieaux N
N Z Med J; 2005 Oct; 118(1223):U1678. PubMed ID: 16224502
[TBL] [Abstract][Full Text] [Related]
19. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
Alexander KP; Newby LK; Cannon CP; Armstrong PW; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
Circulation; 2007 May; 115(19):2549-69. PubMed ID: 17502590
[TBL] [Abstract][Full Text] [Related]
20. Optimal medical management of peripheral arterial disease.
Rice TW; Lumsden AB
Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
